Nephrotic syndrome: Current understanding and future therapies - Kölner UniversitätsPublikationsServer

Diefenhardt, Paul, Osterholt, Thomas and Brinkkoetter, Paul (2022). Nephrotic syndrome: Current understanding and future therapies. Dtsch. Med. Wochenschr., 147 (6). S. 332 - 337. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Full text not available from this repository.

DOI:10.1055/a-1334-2135

Abstract

Advances in basic and clinical research have improved our understanding of the pathomechanisms underlying nephrotic syndrome caused by minimal change disease (MCD) and focal and segmental glomerulosclerosis (FSGS). These advances are reflected in the new 2021 KDIGO-Guidelines, which emphasize the clear distinction between primary, secondary and genetic causes. Proper classification is critical, as it directly affects the therapy of choice. While glucocorticoids still play a central in inducing remission in primary forms, calcineurin inhibitors, mycophenolate mofetil, cyclophosphamide and rituximab (off label) are viable adjuncts/alternatives to reduce or replace glucocorticoids in case of side effects or contraindications. Since SGLT-2-inhibitors have shown renoprotective effects in non-diabetic patients and may help to reduce proteinuria, they should be considered in all (adult) patients with chronic kidney disease, including MCD and FSGS patients. In the near future, Sparsentan, an endothelin type A and angiotensin receptor blocker may be added to the growing arsenal of proteinuria-reducing agents, with a phase 3 trail expected to be completed in late 2022. Finally, we recommend the inclusion of all MCD/FSGS patients in clinical registries (e. g. FOrMe Registry in Germany) to ensure adequate therapy and genetic testing if indicated. In addition, national registries are an invaluable source of clinical data that helps to refine our therapies towards individualized medicine.

Item Type:

Journal Article

Creators:

Creators	Email	ORCID	ORCID Put Code
Diefenhardt, Paul	UNSPECIFIED	UNSPECIFIED	UNSPECIFIED
Osterholt, Thomas	UNSPECIFIED	UNSPECIFIED	UNSPECIFIED
Brinkkoetter, Paul	UNSPECIFIED	UNSPECIFIED	UNSPECIFIED